Campbell IG - Search Results

1

Eccles DM, Englefield P, Soulby MA, Campbell IG. Eccles DM, et al. Among authors: campbell ig. Br J Cancer. 1998 Jun;77(12):2199-203. doi: 10.1038/bjc.1998.366. Br J Cancer. 1998. PMID: 9649133 Free PMC article.

2

LOH and mutation analysis of CDKN2 in primary human ovarian cancers.

Campbell IG, Foulkes WD, Beynon G, Davis M, Englefield P. Campbell IG, et al. Int J Cancer. 1995 Oct 9;63(2):222-5. doi: 10.1002/ijc.2910630213. Int J Cancer. 1995. PMID: 7591208

3

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.

Englefield P, Foulkes WD, Campbell IG. Englefield P, et al. Among authors: campbell ig. Br J Cancer. 1994 Nov;70(5):905-7. doi: 10.1038/bjc.1994.418. Br J Cancer. 1994. PMID: 7947096 Free PMC article.

4

Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma.

Foulkes WD, Englefield P, Campbell IG. Foulkes WD, et al. Among authors: campbell ig. Eur J Cancer. 1994;30A(4):528-30. doi: 10.1016/0959-8049(94)90432-4. Eur J Cancer. 1994. PMID: 8018414

5

A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1.

Campbell IG, Nicolai HM, Foulkes WD, Senger G, Stamp GW, Allan G, Boyer C, Jones K, Bast RC Jr, Solomon E. Campbell IG, et al. Hum Mol Genet. 1994 Apr;3(4):589-94. doi: 10.1093/hmg/3.4.589. Hum Mol Genet. 1994. PMID: 8069304

6

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Foulkes WD, Campbell IG, Stamp GW, Trowsdale J. Foulkes WD, et al. Among authors: campbell ig. Br J Cancer. 1993 Feb;67(2):268-73. doi: 10.1038/bjc.1993.51. Br J Cancer. 1993. PMID: 8094291 Free PMC article.

7

p53 polymorphism in ovarian and breast cancer.

Campbell IG, Eccles DM, Dunn B, Davis M, Leake V. Campbell IG, et al. Lancet. 1996 Feb 10;347(8998):393-4. doi: 10.1016/s0140-6736(96)90569-3. Lancet. 1996. PMID: 8598715 No abstract available.

8

Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.

Bryan EJ, Watson RH, Davis M, Hitchcock A, Foulkes WD, Campbell IG. Bryan EJ, et al. Among authors: campbell ig. Cancer Res. 1996 Feb 15;56(4):719-21. Cancer Res. 1996. PMID: 8631002

9

Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.

Davis M, Hitchcock A, Foulkes WD, Campbell IG. Davis M, et al. Among authors: campbell ig. Cancer Res. 1996 Feb 15;56(4):741-4. Cancer Res. 1996. PMID: 8631007

10

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.

Tavassoli M, Steingrimsdottir H, Pierce E, Jiang X, Alagoz M, Farzaneh F, Campbell IG. Tavassoli M, et al. Among authors: campbell ig. Br J Cancer. 1996 Jul;74(1):115-9. doi: 10.1038/bjc.1996.324. Br J Cancer. 1996. PMID: 8679443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

307 results

Search Page